baber/WOPTO huggingface dataset:
Patent AT-E184785-T1 (AT)
Inventor: LENK ROBERT P
IPC: A61K47/42
Filed: 1994-11-03
Granted: 1999-10-15
Abstract: This invention provides a multilamellar liposome containing an arachidonic acid metabolite, two or more lipid-containing bilayers and two or more aqueous compartments containing a release-inhibiting buffer. Preferred arachidonic acid metabolites are the prostaglandins, particularly PGE1. The liposomal formulations can be used to treat animals, particularly humans, for diseases, disorders or conditions which can be ameliorated by prostaglandins, e.g. disorders characterized by cellular activation and ahesion, inflammation and/or toxemia.
Patent AT-E162107-T1 (AT)
Inventor: FORSLUND KJELL
IPC: D21B1/34
Filed: 1994-10-27
Granted: 1998-01-15
Abstract: PCT No. PCT/SE94/01009 Sec. 371 Date May 22, 1996 Sec. 102(e) Date May 22, 1996 PCT Filed Oct. 27, 1994 PCT Pub. No. WO95/17243 PCT Pub. Date Jun. 29, 1995Mixing devices for mixing a processing agent with a pulp suspension are disclosed including a mixing vessel, an agitator mounted on the surface of the mixing vessel to create a flow of the pulp suspension across the mixing vessel, a processing agent supply for supplying processing agent to the flow of pulp suspension, and a flow divider mounted on the inner surface of the mixing vessel opposite the agitator, in which the flow divider includes a substantially vertical front distribution edge and a pair of arcuate front surfaces extending from that edge to the inner surface of the mixing vessel on opposite sides thereof.
Patent AT-E238407-T1 (AT)
Inventor: JAQUESS PERCY
IPC: C12N9/20
Filed: 1995-01-06
Granted: 2003-05-15
Abstract: An enzyme composition of matter is disclosed for reducing the amount of acylglycerol esters in water comprising a lipase enzyme, a non-ionic emulsifying agent, a water soluble organic acid preservative and a water soluble stabilizer. The lipase enzyme can be used in conjunction with other enzymes. The non-ionic emulsifying agent can comprise an alcohol ethoxylate, the water soluble organic acid preservative can comprise sorbic acid and the water soluble stabilizer can comprise glycerol. A method for treating water containing acylglycerol esters with the foregoing compositions is also disclosed.
Patent AT-E235932-T1 (AT)
Inventor: GRABENKORT RICHARD W
IPC: A61M16/18
Filed: 1995-01-27
Granted: 2003-04-15
Abstract: A connector (20) is provided for mounting on an anesthetic vaporizer (22) to connect the inlet of the vaporizer (22) with a discharge port (42) of a container (24) of liquid anesthetic (26). The connector (20) includes a first coupling (47) attachable to the vaporizer (22) and defining a first passage (61) communicating at one end with the vaporizer inlet. A second coupling (49) is attachable to the container (24) and defines a second passage (68) communicating at one end with the container discharge port (42). A third passage (70) defined by one of the couplings (47, 49) and communicates with one of the first and second passages (61, 68). A combination valve and mounting structure is cooperatively defined by the couplings (47, 49) to accommodate pivoting of the second coupling (49) to a closed position occluding the first and second passages (61, 68), to a raised fill position establishing communication between the first and second passages (61, 68), and to a lowered drain position in which the first and second passages (61, 68) communicate through the third passage (70).
Patent AT-E178444-T1 (AT)
Inventor: WHEATLEY CHARLES E III
IPC: H04B1/04
Filed: 1995-02-01
Granted: 1999-04-15
Abstract: A link quality improvement system for a cellular communication system in which portable units are used to facilitate communication of information signals between system users, via at least one cell-site, using code division multiple access spread spectrum communication signals. The system enables users to improve the quality of reverse communication links from the portable units to the cell-site by providing to each system user a link quality signal indicative of power received at the cell-site relative to an optimum level of received power. At a cell-site communicating with a portable unit associated with a particular system user, the portable unit transmitted power is measured as received at the cell-site. A command signal is generated at the cell-site and transmitted to the portable unit for adjusting portable unit transmitter power. The command signals are also accumulated in order to enable generation of a link quality signal in response thereto. In a preferred implementation the link quality signal is an audible interference signal inducing the system user to adjust orientation of the portable communication unit so as to improve signal quality on the reverse link.
Patent AT-E186220-T1 (AT)
Inventor: FERGUSON MARK W J
IPC: C12P21/08
Filed: 1995-03-29
Granted: 1999-11-15
Abstract: The invention relates to compositions for use in promoting the healing of wounds or fibrotic disorders comprising at least one agent specific to a growth factor and which effects the quantity of active growth factor. Said agent may for example be specific against TGF- beta , TGF- beta 2 or PDGF.
Patent AT-E245164-T1 (AT)
Inventor: FRAZER IAN
IPC: G01N33/574
Filed: 1995-05-17
Granted: 2003-08-15
Abstract: This invention relates to a recombinant papilloma virus L1 protein which can elicit an immune response which recognises papilloma virus VLP including L1 protein and can form extracellularly a multimeric structure or VLP wherein the multimeric structure comprises a pluraility of recombinant papilloma virus L1 proteins. This invention also includes the use of the recombinant papilloma virus L1 protein to detect the presence of papilloma virus and can form the basis of a vaccine for prophylactic and therapeutic use.
Patent AT-E221778-T1 (AT)
Inventor: EFTHYMIOPOULOS CONSTANTIN
IPC: C07D309/28
Filed: 1995-05-24
Granted: 2002-08-15
Abstract: 5-Acetamido-2,3,4,5-tetradeoxy-4-guanidino-<u>D</u>-glycero-<u>D</u>-g alacto-non-2-enopyranosonic acid exhibits antiviral activity in animals, in particular in humans, when administered by mouth via inhalation or insufflation.
Patent AT-E406609-T1 (AT)
Inventor: FLEMING ROBERT
IPC: G01S19/19
Filed: 1995-07-19
Granted: 2008-09-15
Abstract: A network of localizers determines relative locations in three-dimensional space to within 1 cm by cooperatively measuring propagation times of pseudorandom sequences of electromagnetic impulses. Ranging transmissions may include encoded digital information to increase accuracy. The propagation time is determined from a correlator circuit which provides an analog pseudo-autocorrelation function sampled at discrete time bins. The correlator has a number of integrators, each integrator providing a signal proportional to the time integral of the product of the expected pulse sequence delayed by one of the discrete time bins, and the non-delayed received antenna signal. With the impulses organized as doublets the sampled correlator output can vary considerably in shape depending on where the autocorrelation function peak falls in relation to the nearest bin. Using pattern recognition the time of arrival of the received signal can be determined to within a time much smaller than the separation between bins. Because operation of standard CMOS circuitry generates noise over a large frequency range, only low-noise circuitry operates during transmission and reception. To provide the time accuracy necessary for distancing, a high-frequency clock operates during inter-localizer communications. The high-frequency clock uses a phase-lock loop circuit to increase the clock rate and a programmable delay to provide still finer time graduations. A stage in the low-frequency clock uses low-noise circuitry during transmissions and receptions, and standard circuitry at other times.
Patent AT-E248218-T1 (AT)
Inventor: STRINGER BRADLEY MICHAEL JOHN
IPC: C12N15/09
Filed: 1995-10-25
Granted: 2003-09-15
Abstract: The invention relates to chondrocytes and chondrocyte cell-lines for use especially in studying arthritic conditions. The use of articular chondrocyte cell-lines which mineralise calcium to determine potentially beneficial therapeutic agents is disclosed. Further, the means for producing such cell-lines is also disclosed as well as the characteristics of such cell-lines.
Patent AT-E177517-T1 (AT)
Inventor: EASTHAM DAVID RAYMOND
IPC: F16C9/02
Filed: 1995-11-03
Granted: 1999-03-15
Abstract: A plain bearing having a metal backing, a bearing lining secured to the backing and an overlay plated to an interlayer, which is itself plated onto the bearing lining, is disclosed. The bearing lining is formed from an alloy based on aluminum or copper. The overlay is formed of an alloy of zinc with 0.5 to 25% by weight of a metal selected from nickel, cobalt and iron, and the material of the interlayer is selected from nickel and copper.
Patent AT-E176015-T1 (AT)
Inventor: BENTLEY THOMAS RICHARD
IPC: C11D1/04
Filed: 1995-11-13
Granted: 1999-02-15
Abstract: PCT No. PCT/GB95/02651 Sec. 371 Date May 7, 1997 Sec. 102(e) Date May 7, 1997 PCT Filed Nov. 13, 1995 PCT Pub. No. WO96/15315 PCT Pub. Date May 23, 1996A process for recycling fiber products employs an aqueous deinking medium containing an effective amount of a collector chemical. The collector chemical comprises a surface active agent which is or can be derived from lanolin. Alkoxylated lanolin derivatives are preferred.
Patent AT-E202886-T1 (AT)
Inventor: MIES RONALD JOHANNES MARIA
IPC: H04N7/173
Filed: 1996-07-26
Granted: 2001-07-15
Abstract: Installation and method for freezing audiovisual data streams, which installation comprises a video freeze control (2) which is equipped to receive a freeze command signal (FR) to be generated by a user and to detect a predetermined marker in a videosignal read from a memory (1), and, after receipt of the freeze command signal and detection of said marker, to supply a video control signal (VSC) for a video switch (4) and a video stop signal (VS) to interrupt reading of said video signal (VID), which video switch comprises a first input, to which the video signal (VID) read out is fed, and a second input, which is connected to a video stuffing generator which generates a video stuffing signal (VIDSTUFF), wherein the video switch (4) connects its output to the second input if this receives the video control signal (VSC) and otherwise connects its output to the first input; at the point in time when reading of the video signal is interrupted, reading of an associated audio signal (AUD), if applicable, is also interrupted. <IMAGE>
Patent AT-E169740-T1 (AT)
Inventor: RIOCHET DENIS ROBERT MARIE
IPC: G01N33/53
Filed: 1996-05-13
Granted: 1998-08-15
Abstract: Stabilised troponine compsn. (A) for immunoassays is an aq. soln. of troponines I, T and C in the form of a ternary I-T-C complex. Also new is a powder compsn. for prepn. of (A) contg. the 3 troponines and opt. a protein additive and divalent cations (DC).
Patent AT-E177972-T1 (AT)
Inventor: BLANCHARD GILBERT
IPC: B01J23/76
Filed: 1996-01-10
Granted: 1999-04-15
Abstract: PCT No. PCT/FR96/00039 Sec. 371 Date Sep. 9, 1997 Sec. 102(e) Date Sep. 9, 1997 PCT Filed Jan. 10, 1996 PCT Pub. No. WO96/21506 PCT Pub. Date Jul. 18, 1996The invention provides a catalytic composition which is based on a cerium oxide and on at least one other oxide chosen from iron, manganese and praseodymium oxides, which controls H2S emissions in the catalysis of treatment of automobile exhaust gas.
Patent AT-E184368-T1 (AT)
Inventor: BUEHRE WERNER
IPC: F02B3/06
Filed: 1996-01-19
Granted: 1999-09-15
Abstract: A device for the reduction of pollutant emissions from energy conversion machines burning in particular fossil fuels, with a fuel line (KL) to supply the fuel. In addition, an inductive resistor, preferably an electromagnet (14), is connected to the fuel line (KL), producing a magnetic field in the direction of flow of the fuel.
Patent AT-E182064-T1 (AT)
Inventor: GODIN NORMAN DR
IPC: A61L27/00
Filed: 1996-02-28
Granted: 1999-07-15
Abstract: PCT No. PCT/IB96/00149 Sec. 371 Date Sep. 23, 1997 Sec. 102(e) Date Sep. 23, 1997 PCT Filed Feb. 28, 1996 PCT Pub. No. WO96/29954 PCT Pub. Date Oct. 3, 1996A prosthesis in the form of a flexible tube having a substantially uniform cross section is disclosed. The prosthesis comprises a flange (2) for endoscopically placing stitches or clips in a hiatal hernia (3), and a flexible tubular portion (1) enabling the tube to be squeezed by exerting a pressure (F) on the outer surface thereof in order to prevent reflux of the stomach contents into the esophagus. Food can pass freely through the prosthesis in the direction from the esophagus (4) to the stomach (5). The prosthesis is made of a biocompatible polymer optionally containing barium sulphate to make it detectable using X-rays.
Patent AT-E289067-T1 (AT)
Inventor: FISCHER WOLFGANG
IPC: G01N33/48
Filed: 1996-02-24
Granted: 2005-02-15
Abstract: PCT No. PCT/EP96/00774 Sec. 371 Date Aug. 28, 1997 Sec. 102(e) Date Aug. 28, 1997 PCT Filed Feb. 24, 1996 PCT Pub. No. WO96/27794 PCT Pub. Date Sep. 12, 1996A method for the determination of iodide in aqueous solutions, preferably in urine. The process is characterized in that the sample solution is admixed with a chromogen and a peracid solution and the color reaction is evaluated visually or photometrically. In the determination of iodide in urine, the sample is pretreated by means of a purified activated carbon.
Patent AT-E193265-T1 (AT)
Inventor: DAVIES DAVID EIFION
IPC: B65D83/76
Filed: 1996-03-21
Granted: 2000-06-15
Abstract: PCT No. PCT/EP96/01558 Sec. 371 Date Jan. 28, 1998 Sec. 102(e) Date Jan. 28, 1998 PCT Filed Mar. 21, 1996 PCT Pub. No. WO96/32343 PCT Pub. Date Oct. 17, 1996A pump dispenser suitable for striped toothpaste, comprising a pump head [1] and a replaceable reservoir [2] for the toothpaste, in which the toothpaste is packed in radially disposed segments, and the reservoir is locked against rotation relative to the pump head.
Patent AT-E229784-T1 (AT)
Inventor: LEE YANN-PER
IPC: A61F13/511
Filed: 1996-03-20
Granted: 2003-01-15
Abstract: The present invention provides an absorbent article having a topsheet treated with a silicone-based surfactant to impart hydrophilicity. The absorbent article preferably includes a first, apertured, macroscopically expanded, three-dimensional, polymeric topsheet and preferably includes a second, apertured, macroscopically expanded, three-dimensional polymeric topsheet underlying the first topsheet. The multiple topsheets provide improved masking of bodily fluids absorbed and retained by the absorbent core. The first and second topsheets preferably include surfactants which impart hydrophilicity to differing degrees, and which preferably are selected from diverse surfactant categories. The use of a silicone-based surfactant imparts improved tactile qualities to the wearer-contacting surface of the first topsheet in comparison with non-silicone-based surfactants. These characteristics of the silicone-based surfactant provide improved dryness and cleanliness of appearance through low retention of fluid material at or near the surface of the topsheet itself and promoting fluid movement along the wetted surfaces and downward into the absorbent core.
Patent AT-E405645-T1 (AT)
Inventor: ST GEORGE-HYSLOP PETER
IPC: A01K67/027
Filed: 1996-04-29
Granted: 2008-09-15
Abstract: The present invention describes the identification, isolation, sequencing and characterization of two human presenilin genes, PS-1 and PS-2, mutations which lead to Familial Alzheimer's Disease. Also identified are presenilin gene homologues in mice,  C. elegans  and  D. melanogaster.  Nucleic acids and proteins comprising or derived from the presenilins are useful in screening and diagnosing Alzheimer's Disease, in identifying and developing therapeutics for treatment of Alzheimer's Disease, and in producing cell lines and transgenic animals useful as models of Alzheimer's Disease.
Patent AT-E199914-T1 (AT)
Inventor: KALLIO KALLE
IPC: B29C41/00
Filed: 1996-05-02
Granted: 2001-04-15
Abstract: Process for polymerizing or copolymerizing ethylene for manufacturing ethylene polymers or copolymers having a controlled particle size and morphology. Ethylene is polymerized or copolymerized under ethylene polymerizing conditions in the presence of a supported metallocene catalyst, where the average particle size of the catalyst particles is selected within the range of 14-40  mu m and the residence time at the polymerization is selected so as to achieve a polymer where average particle size is between 0.3-0.5 mm and the proportion of fractions between 0.1-0.6 is at least 80 %.
Patent AT-E188545-T1 (AT)
Inventor: WISNIEWSKI JUERGEN
IPC: C22C1/04
Filed: 1997-10-10
Granted: 2000-01-15
Abstract: Tin and zinc based shot for use as ammunition having a diameter of from 1.5 to 5.5 mm, containing, by weight, in addition to tin and the usual unavoidable contaminants, from 12 to 60% of zinc and from 0 to 5% of aluminum, but less than 0.1% of copper, less than 0.1% of iron, and less than 1% of lead.
Patent AT-E239053-T1 (AT)
Inventor: BUEHRING JUERGEN DR
IPC: C08L23/06
Filed: 1997-11-25
Granted: 2003-05-15
Abstract: A polymer composition that is weldable by high frequency welding comprises: (A) 1-80 wt.% of: (i) a copolymer of ethylene with 8-45 wt.% of a comonomer consisting of vinyl esters of 2-8C carboxylic acids, 1-12C alkyl acrylate and methacrylates, optionally with carbon monoxide as a ter-monomer; and/or (ii) an ethylene homo- or copolymer, propylene homo and/or copolymer with 8-45 wt.% grafted units of unsaturated carboxylic acid, dicarboxylic acid, their esters and/or anhydrides, the copolymer has a melt index (190 degrees C, 2.16 kg) of 0.2-7.0 g/10 min, (B) 20-99 wt.% of a polyamide containing thermoplastic polyolefin with a melt index (230 degrees C, 2.16 kg) of 0.5-7.0 g/10 min, that comprises: (i) (B-1) 3-50 wt.% polyamide, (B-2) 50-97 wt.% polyolefin, preferably: (i) a propylene copolymer comprising 10-95 wt.% polypropylene blocks and 5-90 wt.% of a random copolymer block of ethylene, 3-12C  alpha -olefin and optionally diene where the ethylene content of the random copolymer block is 50-95 wt.%; and/or (ii) a mixture of a polypropylene and a copolymer of ethylene, 3-12 alpha -olefin and optionally diene with a wt. ratio of polypropylene to copolymer of 9:1 - 1:9; and (B-3) 0-40 wt.% blending additive.
Patent AT-E203535-T1 (AT)
Inventor: DORFF PETER HANS
IPC: C07D401/12
Filed: 1997-11-17
Granted: 2001-08-15
Abstract: An (N-(pyridinylmethyl)-heterocyclic)ylideneamine compound of the formula <CHEM> wherein R<3>, A, and B are as described below, and its pharmaceutically acceptable salts and prodrugs. Compounds of the formula I and their pharmaceutically acceptable salts and prodrugs are useful in the treatment of addictive disorders, such as the use of tobacco or other nicotine containing products, neurological and mental disorders such as senile dementia of the Alzheimer's type, Parkinson's disease, attentional hyperactivity disorder, anxiety, obesity, Tourette @ s Syndrome and ulcerative colitis.
Patent AT-E186341-T1 (AT)
Inventor: MAEKIPIRTTI SIMO
IPC: D01F6/06
Filed: 1997-03-14
Granted: 1999-11-15
Abstract: A regulation method for regulating the thermobonding processes of synthetic fibre webs and the production processes of synthetic fibres for the preparation of nonwoven fibre fabrics having the desired strength properties. In the method according to the invention, fibres are made from a polymer, especially a polyolefin polymer, using melt spinning methods, and from these fibres, fibre fabric is made using thermal bonding methods. The central processing conditions of both the fibre and the fabric are adapted using the regulation method according to the invention and associated regulation model so that as a result of thermobonding, the desired nonwoven fabric is obtained having regulated strength properties.
Patent AT-E259651-T1 (AT)
Inventor: LACEY DAVID L
IPC: A61K38/22
Filed: 1997-10-15
Granted: 2004-03-15
Abstract: The present invention concerns the use of a KGF-2 protein(s) as a therapeutic agent, suitably formulated in a pharmaceutical composition, for the specific treatment of disease states and medical conditions afflicting tissues and organs such as in the eye, ear, gums, pancreas, urinary bladder, liver and gastrointestinal tract.
Patent AT-E219565-T1 (AT)
Inventor: NAKAI SEIICHI
IPC: F23G5/14
Filed: 1997-04-21
Granted: 2002-07-15
Abstract: The oblique bed wall (6) of the furnace main unit (1) is inclined in a downward direction towards the ash discharge outlet (5), oblique side walls (24R, 24L) are formed in the right and left side walls (1c, 1d) on the inlet (4) side of the furnace main unit (1), and fluidized bed material (S) blown up from the side fluid layers (RS, LS) is guided into the central fluid layer (CS). The fluidized bed material (S) is caused to circulate in succession from the central fluid layer (CS) at the inlet (4) side -> the central fluid layer (CS) at the ash discharge outlet (5) side -> side fluid layers (RS, LS) at the ash discharge outlet (5) side -> side fluid layers (RS, LS) at the inlet (4) side -> central fluid layer (CS) at the inlet (4) side, by means of dispersive air emitted from dispersive air pipes (21A, 21B, 25). By this means, the fluidized bed material (S) is caused to circulate in virtually a horizontal plane without partitioning walls, slow combustion is conducted due to a slow fluid speed, particularly in the drying and pyrolyzing zone, stable combustion is achieved, and generation of carbon monoxide and dioxin is suppressed. <IMAGE>
Patent AT-E206607-T1 (AT)
Inventor: SCHOENFELDT LARS
IPC: A61F13/02
Filed: 1997-05-23
Granted: 2001-10-15
Abstract: A dressing for covering a portion of the anatomical surface of a living being, said dressing being able to adhere to the skin, the mucosa and/or a wound on any portion of a living being without exposing the skin to a significant stress after application and said dressing showing a permanent deformation created before, during or after application of the dressing and wherein the dressing is optionally covered in part or fully by one or more release liners or cover films to be removed before or during application.
Patent AT-E320811-T1 (AT)
Inventor: KAHN MICHAEL
IPC: C07D487/04
Filed: 1997-08-05
Granted: 2006-04-15
Abstract: beta -sheet mimetics and methods relating to the same are disclosed. The  beta -sheet mimetics have utility as protease and kinase inhibitors, as well as inhibitors of transcription factors. Methods of the invention include administration of a  beta -sheet mimetic, or use of the same for the manufacture of a medicament for treatment of a variety of conditions associated with the targeted protease, kinase and/or transcription factor.
Patent AT-E240724-T1 (AT)
Inventor: LEFEBVRE HERVE
IPC: A61K31/00
Filed: 1997-08-29
Granted: 2003-06-15
Abstract: The invention concerns a novel use of antagonists of the 5-HT4 receptor in pathological conditions where the aldosterone and cortisol blood levels are abnormally high.
Patent AT-E192054-T1 (AT)
Inventor: GROLLA HERBERT DIPL-ING
IPC: B22C19/00
Filed: 1998-03-04
Granted: 2000-05-15
Abstract: The apparatus with a first seating unit (6, 7) for rotating mould boxes is designed so that it can seat and hold securely (during rotation) one or more mould boxes. It is characterised by the presence of a second, synchronously driven seating unit (8, 9) which is located next to the first seating unit, and is angularly offset through 90 degrees .
Patent AT-E221603-T1 (AT)
Inventor: GROETZINGER STEPHAN
IPC: E04B1/41
Filed: 1998-09-25
Granted: 2002-08-15
Abstract: The anchoring bolt has a plate embedded in the surface of a concrete component, with tensioning pins on one side of the plate received within the concrete component and an anchor bolt shaft projecting from the plate on the opposite side for reception in a concrete component on the opposite side of the coupling. A rigid coupling is provided between the plate and the anchor bolt shaft, the thickness of the plate ensuring a flexure resistance greater than the applied torque.